In 2026, cough, cold and allergy (hay fever) remedies in France delivers subdued value growth of 2% to EUR575 million, trailing the typical moderate expansion seen in Western Europe, as ongoing regulatory tightening and a weak cold season limited a true recovery after the contraction of the prior year. The withdrawal of oral pseudoephedrine-based combinations from pharmacy shelves drives a marked shift in purchasing patterns, redirecting demand towards single-ingredient, trust-certified and preventive solutions while forcing both established and emerging players to innovate rapidly within a stricter regulatory and economic context. The landscape is shaped by consumer preferences for safety, natural ingredients, and evidence-backed claims. Pharmacies continue to control the vast majority of sales, but e-commerce, though still a minor channel, is gaining ground, and future growth will depend on the ability to adapt to evolving compliance requirements and capitalise on the rising focus on wellness and prevention. Brands seeking to succeed must prioritise regulatory agility, scientific substantiation, and transparent marketing, while actively responding to shifts in allergy prevalence, climate trends, and heightened consumer scrutiny.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in France with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in France, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Cough, Cold and Allergy (Hay Fever) Remedies in France report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in France?
- Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in France?
- How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in France?
- How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in France?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Regulatory withdrawal and a weak cold season leave market facing a mechanical rebound
Pseudoephedrine withdrawal reshapes remedies toward single-ingredient products
Scientific substantiation become differentiators as OTC brands pivot toward preventive wellness
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Pierre Fabre and P&G Health will drive innovation as natural solutions gain traction
Antihistamines will lead growth in cough, cold and allergy (hay fever) remedies
Pseudoephedrine ban will spark a shift to herbal launches and medical devices
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Solinest leverages self-indulgence trend to reinforce leadership
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies leads distribution through exclusivity as regulatory barriers persist
Atida and Redcare thrive as online pharmacy faces regulatory headwinds
Chart 1 Retail Channels 2021-2026
P&G uses sweetener adaptation to position Vorja lozenges as premium trusted choices
Grimberg Laboratories uses barrier-type formulations to pivot toward prevention
Sanofi and P&G transform reverse-switch constraints into growth opportunities
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Cough, Cold and Allergy (Hay Fever) Remedies
- Antihistamines/Allergy Remedies (Systemic)
-
- Paediatric Allergy Remedies
- Paediatric Cough/Cold Remedies
- Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
- Cough Remedies
-
- Nasal Sprays
- Oral Decongestants
- Inhalant Decongestants
- Decongestant Rubs
- Nasal Decongestant Drops
- Nasal Decongestant Plasters
- Medicated Confectionery
- Pharyngeal Preparations
Cough, Cold and Allergy (Hay Fever) Remedies
This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!